ARCHIVES

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

Guest Editorial: Learning from the Power Morcellation Fiasco: Government Must Do More to Regulate Devices

September 12, 2014

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Panel Unenthused About New Toxicity Testing Program

December 15, 1978

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003